Peter Niclas Broer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Peter Niclas Broer has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Hans-Günther Machens
Department of Plastic and Hand Surgery, Klinikum Rechts der Isar, Technical University Munich, 81675 Munich, Germany
4 shared publications - Samuel Knoedler
Department of Plastic Surgery and Hand Surgery, TUM University Hospital Munich, Ismaninger Str. 22, 81675 Munich, Germany
4 shared publications - Martin Kauke-Navarro
Division of Plastic Surgery, Department of Surgery, Yale School of Medicine, New Haven, USA
3 shared publications - Andrea Sisti
Division of Plastic Surgery and Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Jacksonville, FL 32224, USA
2 shared publications - Antonio Jorge Forte
Center for Digital Health, Mayo Clinic, Rochester, MN 55905, USA
2 shared publications - Bohdan Pomahac
Department of Surgery, Division of Plastic Surgery, Yale School of Medicine, New Haven, CT, United States
2 shared publications
Latest Publications
- Open Access
- 6 June 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (6) , 338
One Surgery, Two Solutions: A Systematic Review of Combined Autologous Breast Reconstruction and Lymphatic Surgery
Simultaneous autologous breast reconstruction (ABR) and lymphatic surgery has emerged as a strategy to address breast cancer-related lymphedema (BCRL) while restoring breast contour within a single operative procedure. In light of the diversity of surgical strategies, we aimed to evaluate the current literature on combined ABR and lymphatic surgery, with particular focus on surgical techniques, clinical outcomes, complications, and patient-reported satisfaction. A systematic review was conducted according to PRISMA guidelines and registered in PROSPERO (CRD420251135446). Medline, Embase, CENTRAL, Web of Science, and PubMed were searched through 9 January 2026 Studies reporting outcomes of simultaneous ABR and lymphatic reconstruction were included. Data on surgical techniques, complications, changes in limb volume and cellulitis incidence, and patient-reported outcomes were extracted. Twenty-seven studies including 499 patients (mean follow-up 23 months) were analyzed. The most common approach was a chimeric deep inferior epigastric perforator (DIEP) flap with inguinal lymph nodes (459 patients), followed by ABR with a separate vascularized lymph node transfer and ABR with lymphovenous anastomosis. Most studies reported postoperative reductions in limb volume and cellulitis, with cellulitis reduction rates up to 100%. Patient-reported outcomes (LYMQOL, ULL-27, LYMPH-Q) showed improved quality of life. Complication rates were low, including 4% seroma and 1% flap loss after chimeric DIEP. Simultaneous ABR and lymphatic reconstruction is feasible and associated with improved clinical and patient-reported outcomes. However, heterogeneity limits comparison between the different surgical techniques, and prospective studies with standardized outcomes measurements are needed.
- 6 June 2026
- Published by MDPI AG in Current Oncology
- Vol. 33 (6) , 338
Open AccessOne Surgery, Two Solutions: A Systematic Review of Combined Autologous Breast Reconstruction and Lymphatic Surgery
Simultaneous autologous breast reconstruction (ABR) and lymphatic surgery has emerged as a strategy to address breast cancer-related lymphedema (BCRL) while restoring breast contour within a single operative procedure. In light of the diversity of surgical strategies, we aimed to evaluate the current literature on combined ABR and lymphatic surgery, with particular focus on surgical techniques, clinical outcomes, complications, and patient-reported satisfaction. A systematic review was conducted according to PRISMA guidelines and registered in PROSPERO (CRD420251135446). Medline, Embase, CENTRAL, Web of Science, and PubMed were searched through 9 January 2026 Studies reporting outcomes of simultaneous ABR and lymphatic reconstruction were included. Data on surgical techniques, complications, changes in limb volume and cellulitis incidence, and patient-reported outcomes were extracted. Twenty-seven studies including 499 patients (mean follow-up 23 months) were analyzed. The most common approach was a chimeric deep inferior epigastric perforator (DIEP) flap with inguinal lymph nodes (459 patients), followed by ABR with a separate vascularized lymph node transfer and ABR with lymphovenous anastomosis. Most studies reported postoperative reductions in limb volume and cellulitis, with cellulitis reduction rates up to 100%. Patient-reported outcomes (LYMQOL, ULL-27, LYMPH-Q) showed improved quality of life. Complication rates were low, including 4% seroma and 1% flap loss after chimeric DIEP. Simultaneous ABR and lymphatic reconstruction is feasible and associated with improved clinical and patient-reported outcomes. However, heterogeneity limits comparison between the different surgical techniques, and prospective studies with standardized outcomes measurements are needed.
- Open Access
- 29 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7686
Cutting Risk, Not Just Skin—An International Survey on the Role of Preoperative Lab Values in Risk Stratification for Plastic and Reconstructive Surgery
Background/Objectives: Plastic and reconstructive surgery (PRS) is characterized by its wide range of techniques and procedures, aiming to address the need for individualized treatment approaches. As PRS is predominantly performed in an elective and non-emergency setting, a thorough preoperative risk assessment through standardized diagnostics remains essential. Lab testing is often routinely performed, yet its overall role and how specific parameters are currently used to stratify risk in PRS is poorly understood. We herein aim to explore the role of preoperative lab value testing and characterize current practices, perceived importance, and variability in their use for risk stratification. Methods: We conducted an anonymous, web-based cross-sectional survey of international PRS surgeons. Survey items captured demographics, routine preoperative assessment methods, ordering frequency of laboratory tests, and their perceived importance. Group comparisons were stratified by work setting, years of experience, and PRS subspecialization. Results: A total of 140 PRS surgeons from 24 countries completed the survey. Clinical evaluation (97.9%) and laboratory testing (84.3%) were the most common risk assessment methods investigated in our study; 70.7% agreed that preoperative lab values are important for surgical risk stratification while 64.3% would adopt a standardized lab-based risk assessment tool. The most ordered lab tests were hemoglobin (80.0%), hematocrit (76.4%), platelets (69.3%), creatinine (68.6%), and white blood cell count (67.1%). Hospital-based PRS surgeons ordered creatinine, WBC, INR and albumin more often and rated albumin of greater importance compared with PRS surgeons based in private practice. Conclusions: Preoperative labs are widely used in PRS with emphasis on hematologic and coagulation parameters, in both hospitals and private practices. Broad consensus on the importance of preoperative lab values in surgical risk stratification and a willingness to adopt a standardized, lab-based risk assessment tool highlight the need to harmonize current practice and integrate specific labs into standardized procedure-specific risk stratification.
- 29 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (21) , 7686
Open AccessCutting Risk, Not Just Skin—An International Survey on the Role of Preoperative Lab Values in Risk Stratification for Plastic and Reconstructive Surgery
Background/Objectives: Plastic and reconstructive surgery (PRS) is characterized by its wide range of techniques and procedures, aiming to address the need for individualized treatment approaches. As PRS is predominantly performed in an elective and non-emergency setting, a thorough preoperative risk assessment through standardized diagnostics remains essential. Lab testing is often routinely performed, yet its overall role and how specific parameters are currently used to stratify risk in PRS is poorly understood. We herein aim to explore the role of preoperative lab value testing and characterize current practices, perceived importance, and variability in their use for risk stratification. Methods: We conducted an anonymous, web-based cross-sectional survey of international PRS surgeons. Survey items captured demographics, routine preoperative assessment methods, ordering frequency of laboratory tests, and their perceived importance. Group comparisons were stratified by work setting, years of experience, and PRS subspecialization. Results: A total of 140 PRS surgeons from 24 countries completed the survey. Clinical evaluation (97.9%) and laboratory testing (84.3%) were the most common risk assessment methods investigated in our study; 70.7% agreed that preoperative lab values are important for surgical risk stratification while 64.3% would adopt a standardized lab-based risk assessment tool. The most ordered lab tests were hemoglobin (80.0%), hematocrit (76.4%), platelets (69.3%), creatinine (68.6%), and white blood cell count (67.1%). Hospital-based PRS surgeons ordered creatinine, WBC, INR and albumin more often and rated albumin of greater importance compared with PRS surgeons based in private practice. Conclusions: Preoperative labs are widely used in PRS with emphasis on hematologic and coagulation parameters, in both hospitals and private practices. Broad consensus on the importance of preoperative lab values in surgical risk stratification and a willingness to adopt a standardized, lab-based risk assessment tool highlight the need to harmonize current practice and integrate specific labs into standardized procedure-specific risk stratification.
- 1 February 2024
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 90, 149-160
Isolated and combined breast augmentation in transgender patients: Multi-institutional insights into early outcomes and risk factors
- 1 February 2024
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 90, 149-160
Isolated and combined breast augmentation in transgender patients: Multi-institutional insights into early outcomes and risk factors
- Open Access
- 4 December 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (2) , 684-699
Racial disparities in surgical outcomes after mastectomy in 223 000 female breast cancer patients: a retrospective cohort study
Background: Breast cancer mortality and treatment differ across racial groups. It remains unclear whether such disparities are also reflected in perioperative outcomes of breast cancer patients undergoing mastectomy. Study design: The authors reviewed the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database (2008–2021) to identify female patients who underwent mastectomy for oncological purposes. The outcomes were stratified by five racial groups (white, Black/African American, Asian, American Indian/Alaska Native, and Native Hawaiian/Pacific Islander) and included 30-day mortality, reoperation, readmission, surgical and medical complications, and non-home discharge. Results: The study population included 222 947 patients, 68% (n=151 522) of whom were white, 11% (n=23 987) Black/African American, 5% (n=11 217) Asian, 0.5% (n=1198) American Indian/Alaska Native, and 0.5% (n=1018) Native Hawaiian/Pacific Islander. While 136 690 (61%) patients underwent partial mastectomy, 54 490 (24%) and 31 767 (14%) women received simple and radical mastectomy, respectively. Overall, adverse events occurred in 17 222 (7.7%) patients, the largest portion of which were surgical complications (n=7246; 3.3%). Multivariable analysis revealed that being of Asian race was protective against perioperative complications [odds ratio (OR)=0.71; PPPPP=0.045) following partial mastectomy was significantly increased. Conclusion: The authors identified American Indian/Alaska Native women as particularly vulnerable to complications following mastectomy. Asian patients experienced the lowest rate of complications in the perioperative period. The authors’ analyses revealed comparable confounder-adjusted outcomes following partial and complete mastectomy between Black and white races. Their findings call for care equalization in the field of breast cancer surgery.
- 4 December 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (2) , 684-699
Open AccessRacial disparities in surgical outcomes after mastectomy in 223 000 female breast cancer patients: a retrospective cohort study
Background: Breast cancer mortality and treatment differ across racial groups. It remains unclear whether such disparities are also reflected in perioperative outcomes of breast cancer patients undergoing mastectomy. Study design: The authors reviewed the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database (2008–2021) to identify female patients who underwent mastectomy for oncological purposes. The outcomes were stratified by five racial groups (white, Black/African American, Asian, American Indian/Alaska Native, and Native Hawaiian/Pacific Islander) and included 30-day mortality, reoperation, readmission, surgical and medical complications, and non-home discharge. Results: The study population included 222 947 patients, 68% (n=151 522) of whom were white, 11% (n=23 987) Black/African American, 5% (n=11 217) Asian, 0.5% (n=1198) American Indian/Alaska Native, and 0.5% (n=1018) Native Hawaiian/Pacific Islander. While 136 690 (61%) patients underwent partial mastectomy, 54 490 (24%) and 31 767 (14%) women received simple and radical mastectomy, respectively. Overall, adverse events occurred in 17 222 (7.7%) patients, the largest portion of which were surgical complications (n=7246; 3.3%). Multivariable analysis revealed that being of Asian race was protective against perioperative complications [odds ratio (OR)=0.71; PPPPP=0.045) following partial mastectomy was significantly increased. Conclusion: The authors identified American Indian/Alaska Native women as particularly vulnerable to complications following mastectomy. Asian patients experienced the lowest rate of complications in the perioperative period. The authors’ analyses revealed comparable confounder-adjusted outcomes following partial and complete mastectomy between Black and white races. Their findings call for care equalization in the field of breast cancer surgery.
- 1 December 2023
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 89, 40-50
The significance of timing in breast reconstruction after mastectomy: An ACS-NSQIP analysis
- 1 December 2023
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 89, 40-50
The significance of timing in breast reconstruction after mastectomy: An ACS-NSQIP analysis
- Open Access
- 19 October 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (10) , 1739
A Ready-to-Use Grading Tool for Facial Palsy Examiners—Automated Grading System in Facial Palsy Patients Made Easy
Background: The grading process in facial palsy (FP) patients is crucial for time- and cost-effective therapy decision-making. The House-Brackmann scale (HBS) represents the most commonly used classification system in FP diagnostics. This study investigated the benefits of linking machine learning (ML) techniques with the HBS. Methods: Image datasets of 51 patients seen at the Department of Plastic, Hand, and Reconstructive Surgery at the University Hospital Regensburg, Germany, between June 2020 and May 2021, were used to build the neural network. A total of nine facial poses per patient were used to automatically determine the HBS. Results: The algorithm had an accuracy of 98%. The algorithm processed the real patient image series (i.e., nine images per patient) in 112 ms. For optimized accuracy, we found 30 training runs to be the most effective training length. Conclusion: We have developed an easy-to-use, time- and cost-efficient algorithm that provides highly accurate automated grading of FP patient images. In combination with our application, the algorithm may facilitate the FP surgeon’s clinical workflow.
- 19 October 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (10) , 1739
Open AccessA Ready-to-Use Grading Tool for Facial Palsy Examiners—Automated Grading System in Facial Palsy Patients Made Easy
Background: The grading process in facial palsy (FP) patients is crucial for time- and cost-effective therapy decision-making. The House-Brackmann scale (HBS) represents the most commonly used classification system in FP diagnostics. This study investigated the benefits of linking machine learning (ML) techniques with the HBS. Methods: Image datasets of 51 patients seen at the Department of Plastic, Hand, and Reconstructive Surgery at the University Hospital Regensburg, Germany, between June 2020 and May 2021, were used to build the neural network. A total of nine facial poses per patient were used to automatically determine the HBS. Results: The algorithm had an accuracy of 98%. The algorithm processed the real patient image series (i.e., nine images per patient) in 112 ms. For optimized accuracy, we found 30 training runs to be the most effective training length. Conclusion: We have developed an easy-to-use, time- and cost-efficient algorithm that provides highly accurate automated grading of FP patient images. In combination with our application, the algorithm may facilitate the FP surgeon’s clinical workflow.
- Open Access
- 7 September 2020
- Vol. 91 (3) , e2020082
Oil injection for cosmetic enhancement of the upper extremities: a case report and review of literature.
Here the authors report a case of complications occured after injection of a site enhancement oil in the upper extremity for cosmetic muscles' volume enhancement and a literature review on the topic. The medical and sports communities should be aware of the secondary effects of site enhancement oils use, which could bring to severe complications.
- 7 September 2020
- Vol. 91 (3) , e2020082
Open AccessOil injection for cosmetic enhancement of the upper extremities: a case report and review of literature.
Here the authors report a case of complications occured after injection of a site enhancement oil in the upper extremity for cosmetic muscles' volume enhancement and a literature review on the topic. The medical and sports communities should be aware of the secondary effects of site enhancement oils use, which could bring to severe complications.
- Open Access
Postmastectomy Radiation Therapy (PMRT) before and after 2-Stage Expander-Implant Breast Reconstruction: A Systematic Review
Background: In those undergoing treatment for breast cancer, evidence has demonstrated a significant improvement in survival, and a reduction in the risk of local recurrence in patients who undergo postmastectomy radiation therapy (PMRT). There is uncertainty about the optimal timing of PMRT, whether it should be before or after tissue expander or permanent implant placement. This study aimed to summarize the data reported in the literature on the effect of the timing of PMRT, both preceding and following 2-stage expander-implant breast reconstruction (IBR), and to statistically analyze the impact of timing on infection rates and the need for explantation. Methods: A comprehensive systematic review of the literature was conducted using the PubMed/Medline, Ovid, and Cochrane databases without timeframe limitations. Articles included in the analysis were those reporting outcomes data of PMRT in IBR published from 2009 to 2017. Chi-square statistical analysis was performed to compare infection and explantation rates between the two subgroups at p < 0.05. Results: A total of 11 studies met the inclusion criteria for this study. These studies reported outcomes data for 1565 total 2-stage expander-IBR procedures, where PMRT was used (1145 before, and 420 after, implant placement). There was a statistically significant higher likelihood of infection following pre-implant placement PMRT (21.03%, p = 0.000079), compared to PMRT after implant placement (9.69%). There was no difference in the rate of explantation between pre-implant placement PMRT (12.93%) and postimplant placement PMRT (11.43%). Conclusion: This study suggests that patients receiving PMRT before implant placement in 2-stage expander–implant based reconstruction may have a higher risk of developing an infection.
Open AccessPostmastectomy Radiation Therapy (PMRT) before and after 2-Stage Expander-Implant Breast Reconstruction: A Systematic Review
Background: In those undergoing treatment for breast cancer, evidence has demonstrated a significant improvement in survival, and a reduction in the risk of local recurrence in patients who undergo postmastectomy radiation therapy (PMRT). There is uncertainty about the optimal timing of PMRT, whether it should be before or after tissue expander or permanent implant placement. This study aimed to summarize the data reported in the literature on the effect of the timing of PMRT, both preceding and following 2-stage expander-implant breast reconstruction (IBR), and to statistically analyze the impact of timing on infection rates and the need for explantation. Methods: A comprehensive systematic review of the literature was conducted using the PubMed/Medline, Ovid, and Cochrane databases without timeframe limitations. Articles included in the analysis were those reporting outcomes data of PMRT in IBR published from 2009 to 2017. Chi-square statistical analysis was performed to compare infection and explantation rates between the two subgroups at p < 0.05. Results: A total of 11 studies met the inclusion criteria for this study. These studies reported outcomes data for 1565 total 2-stage expander-IBR procedures, where PMRT was used (1145 before, and 420 after, implant placement). There was a statistically significant higher likelihood of infection following pre-implant placement PMRT (21.03%, p = 0.000079), compared to PMRT after implant placement (9.69%). There was no difference in the rate of explantation between pre-implant placement PMRT (12.93%) and postimplant placement PMRT (11.43%). Conclusion: This study suggests that patients receiving PMRT before implant placement in 2-stage expander–implant based reconstruction may have a higher risk of developing an infection.
- 1 January 2019
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 47 (1) , 73-79
Female eye attractiveness – Where beauty meets science
- 1 January 2019
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 47 (1) , 73-79
Female eye attractiveness – Where beauty meets science